Naturally occurring B-cell responses to breast cancer Julia A. Coronella-WoodEvan M. Hersh Review 15 August 2003 Pages: 715 - 738
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model Maryam ParvizCynthia S. ChinHarry D. Bear Original Article 14 August 2003 Pages: 739 - 750
Anti-Her-2/neu-IL-2 or heregulin-IL-2 fusions proteins redirect non-tumor specific CTL to the tumor site for tumor eradication Joseph Lustgarten Original Article 19 June 2003 Pages: 751 - 760
Identification of new MHC-restriction elements for presentation of the p210BCR-ABL fusion region to human cytotoxic T lymphocytes Ji-Yao SunDavid SenitzerK. K. Wong Jr Original Article 17 October 2003 Pages: 761 - 770
Natural CD8+ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumors Panagiota A. SotiropoulouSonia A. PerezConstantin N. Baxevanis Original Article 10 September 2003 Pages: 771 - 779
Heparan sulphate epitope–expression is associated with the inflammatory response in metastatic malignant melanoma Monique R. BernsenToon F. C. M. SmetsersAnnika Håkansson Short Communication 10 September 2003 Pages: 780 - 783